Author:
Polley Eric,Zhao Yingdong
Publisher
Springer International Publishing
Reference7 articles.
1. Salgado R, Moore H, Martens JWM, Lively T, Malik S, Mcdermott U, et al. Societal challenges of precision medicine: bringing order to chaos on behalf of the IBCD-faculty. Eur J Cancer. 2017;84:325–34. https://ac-els-cdn-com.kuleuven.ezproxy.kuleuven.be/S0959804917311486/1-s2.0-S0959804917311486-main.pdf?_tid=51419b46-8fd3-4835-bb76-2de50e387c87&acdnat=1524130410_d4b2eabe31b3628a238944d08d8cb499 .
2. CDER, CBER. Master protocols: efficient clinical trial design strategies to expedite development of oncology drugs and biologics (Draft) [Internet]. Guidance. 2018. https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm.
3. Renfro LA, Sargent DJ. Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples. Ann Oncol. 2017;28:34–43.
4. Simon R, Polley E. Clinical trials for precision oncology using next-generation sequencing. Per Med. 2013;10:485–95.
5. Do K, O’Sullivan Coyne G, Chen AP. An overview of the NCI precision medicine trials-NCI MATCH and MPACT. Chin Clin Oncol. 2015;4:31. http://www.ncbi.nlm.nih.gov/pubmed/26408298 .